Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Contemporary Approaches to Perioperative IV Fluid Therapy

Myles PS, Andrews S, Nicholson J, Lobo DN, Mythen M

(2017), World J Surg, 41(10), 2457-63

DOI: 10.1007/s00268-017-4055-y

Exploring Decision Pathways in Challenging Airway Management Episodes

Schnittker R, Marshall S, Horberry T, Young K, Lintern G

(2017), J Cogn Eng Decis Mak, 11(4), 353-70

DOI: 10.1177/1555343417716843

Traumatic injury and perceived injustice: fault attributions matter in a "no-fault" compensation state

Ioannou LJ, Cameron PA, Gibson SJ, Gabbe BJ, Ponsford J, Jennings PA, Arnold CA, Gwini SM, Georgiou-Karistianis N, Giummarra MJ

(2017), PLoS One, 12(6), e0178894

DOI: 10.1371/journal.pone.0178894

Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia

Myles PS, Shulman MA, Heritier S, Wallace S, McIlroy DR, McCluskey S, Sillar I, Forbes A

(2017), BMJ Open, 7(8), e015828

DOI: 10.1136/bmjopen-2017-015828

The cognitive aids in medicine assessment tool (CMAT) applied to five neonatal resuscitation algorithms

McLanders ML, Marshall SD, Sanderson PM, Liley HG

(2017), J Perinatol, 37(4), 387-93

DOI: 10.1038/jp.2016.235

A survey of Australian and New Zealand anaesthetists' attitudes towards resuscitation orders in the perioperative setting

Keon-Cohen Z, Myles PS, Story DA

(2017), Anaesth Intensive Care, 45(3), 396-402

Making robust assessments of specialist trainees' workplace performance

Weller JM, Castanelli DJ, Chen Y, Jolly B

(2017), Br J Anaesth, 118(2), 207-14

DOI: 10.1093/bja/aew412

Basic mechanisms of platelet receptor shedding

Andrews RK, Gardiner EE

(2017), Platelets, 28(4), 319-24

DOI: 10.1080/09537104.2016.1235690

Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL)

Curtis DJ

(2017), Br J Haematol, 177(2), 169-70

DOI: 10.1111/bjh.14559

The cutting edge of platelets

Andrews RK, Gardiner EE

(2017), Platelets, 28(4), 317-8

DOI: 10.1080/09537104.2017.1338397

Accelerating early drug development: come on down under!

Wei A

(2017), Ann Oncol, 28(7), 1655-7

DOI: 10.1093/annonc/mdx101

Utility of CRISPR/Cas9 systems in hematology research

Lucas D, O'Leary HA, Ebert BL, Cowan CA, Tremblay CS

(2017), Exp Hematol, 54, 1-3

DOI: 10.1016/j.exphem.2017.06.006

Up-Regulation of the Vitamin D Pathway in Acute Myeloid Leukemia

Casan JML, Ghotb S, Morgan S, Wei AH, Ting SB

(2017), Ann Hematol Oncol, 4(3), 1141

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Dàhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B?chner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, Làwenberg B, Bloomfield CD

(2017), Blood, 129(4), 424-47

DOI: 10.1182/blood-2016-08-733196

Venetoclax and obinutuzumab in chronic lymphocytic leukemia

Fischer K, Al-Sawaf O, Fink AM, Dixon M, Bahlo J, Warburton S, Kipps TJ, Weinkove R, Robinson S, Seiler T, Opat S, Owen C, L?pez J, Humphrey K, Humerickhouse R, Tausch E, Frenzel L, Eichhorst B, Wendtner CM, Stilgenbauer S, Langerak AW, van Dongen JJM, Bàttcher S, Ritgen M, Goede V, Mobasher M, Hallek M

(2017), Blood, 129(19), 2702-5

DOI: 10.1182/blood-2017-01-761973

Challenges and opportunities in protease-activated receptor drug development

Hamilton JR, Trejo J

(2017), Annu Rev Pharmacol Toxicol, 57, 349-73

DOI: 10.1146/annurev-pharmtox-011613-140016

Malaria after international travel: a GeoSentinel analysis, 2003-2016

Angelo KM, Libman M, Caumes E, Hamer DH, Kain KC, Leder K, Grobusch MP, Hagmann SH, Kozarsky P, Lalloo DG, Lim PL, Patimeteeporn C, Gautret P, Odolini S, Chappuis F, Esposito DH; GeoSentinel Network

(2017), Malar J, 16, 293

DOI: 10.1186/s12936-017-1936-3

Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Thieblemont C, Tilly H, Gomes da Silva M, Casasnovas RO, Fruchart C, Morschhauser F, Haioun C, Lazarovici J, Grosicka A, Perrot A, Trotman J, Sebban C, Caballero D, Greil R, van Eygen K, Cohen AM, Gonzalez H, Bouabdallah R, Oberic L, Corront B, Choufi B, Lopez-Guillermo A, Catalano J, Van Hoof A, Briere J, Cabe¡adas J, Salles G, Gaulard P, Bosly A, Coiffier B

(2017), J Clin Oncol, 35(22), 2473-81

DOI: 10.1200/JCO.2017.72.6984

Diagnosis in subdural myeloid sarcoma

Lackey A, Laing B, Perkins A, Bryant M

(2017), Neuroradiol J, 30(3), 269-73

DOI: 10.1177/1971400916689343

Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2

Gurusinghe S, Cox AG, Rahman R, Chan ST, Muljadi R, Singh H, Leaw B, Mockler JC, Marshall SA, Murthi P, Lim R, Wallace EM

(2017), Placenta, 60, 74-85

DOI: 10.1016/j.placenta.2017.10.008

234 235 236 237 238